Author

Anna Dyas

University of Cambridge

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Anna C. ObenaufiD· 1 shared Cissy YongiD· 1 shared Daniel Muñoz‐EspíniD· 1 shared Grant Duncan StewartiD· 1 shared Jarno DrostiD· 1 shared Jianfeng GeiD· 1 shared Leticia CastilloniD· 1 shared Ludovic Wesolowski· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anna C. ObenaufORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Mechanisms of resistance to VHL loss-induced genetic and pharmacological vulnerabilities

Jianfeng Ge, Shoko Hirosue, Leticia Castillon, Saroor A. Patel, Ludovic Wesolowski, Anna Dyas, Cissy Yong, Sanne de Haan, Jarno Drost, Grant Duncan Stewart, Anna C. Obenauf, Daniel Muñoz‐Espín, Sakari Vanharanta

This study identifies HIF1A as a key inhibitor of VHL null cell fitness and shows that combined VHL/HIF1A inactivation can confer resistance to PROTAC-based therapies.

EMBO Molecular Medicine · Dec 19, 2025Peer-reviewedCancer Biology